Baltimore-All phakic IOLs are associated with potential problems, although evolution in implant design has been accompanied by declining complication rates, said Walter J. Stark, MD.
Walter J. Stark, MD
Advertisement
Dr. Stark, professor of ophthalmology, The Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore.
Articles by Walter J. Stark, MD
Advertisement
Latest Updated Articles
- Evolution brings greater safety profile to phakic IOLs
Published: May 1st 2003 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Glaukos receives FDA approval for Epioxa topical therapy for keratoconus
2
AAO 2025: Kenneth C. Fan, MD, sees vision gains with MCO-010 in Stargardt disease
3
AAO 2025: Understanding and diagnosing endophthalmitis
4
AAO 2025: Diana Do reviews the real-world use of aflibercept 8 mg
5
.png "Optometry Times"){kind=logo}
